Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Guillain-Barre syndrome after snakebite: a case report and systematic review
1Intensive Care Unit, Department of Anesthesiology and Reanimation, Izmir Katip Celebi University Atatürk Education and Research Hospital, 35360 Izmir, Turkey
2Intensive Care Unit, Department of Anesthesiology and Reanimation, Izmir Acıbadem Kent Hospital, 35630 Izmir, Turkey
DOI: 10.22514/sv.2024.090 Vol.20,Issue 8,August 2024 pp.95-102
Submitted: 27 September 2023 Accepted: 06 February 2024
Published: 08 August 2024
*Corresponding Author(s): Mensure Yımaz Çakırgöz E-mail: mensure.cakirgoz@sbu.edu.tr
Guillain-Barré Syndrome (GBS) is a polyneuropathy characterized by acute-onset and immune-mediated processes, triggered by various factors. The occurence of GBS in connection with snakebites is rare. In this report, we present a rare clinical case with neuro-muscular and hematological complications following a snakebite, leading to flask quadriplegia on the 14th day during intensive care follow-up. Cerebrospinal fluid (CSF) analysis indicated albumin-cytological dissociation, and Electromyography (EMG) revealed findings consistent with acute motor axonal neuropathy, resulting in a diagnosis of GBS. After undergoing plasmapheresis once, the patient swiftly developed refractory septic shock, leading to a fatal outcome. In this study, we report a GBS case as a conseqeunce of snakebite together with a systematic review of the medical literature on the development of GBS after snakebite. Although current case reports and findings have broadened the scope of etiologic hypotheses for GBS including snake envenomation, further studies are needed to confirm the association between GBS following snakebite.
Guillain-Barre syndrome; Snakebite; Acute motor axonal neuropathy
Mensure Yımaz Çakırgöz,Murat Aksun,Damlanur Üstün,Özgün Yılmaz,Mert Akan. Guillain-Barre syndrome after snakebite: a case report and systematic review. Signa Vitae. 2024. 20(8);95-102.
[1] Shang P, Feng J, Wu W, Zhang HL. Intensive care and treatment of severe Guillain-Barré syndrome. Frontiers in Pharmacology. 2021; 12: 608130.
[2] Çakırgöz MY, Duran E, Topuz C, Kara D, Turgut N, Türkmen ÜA, et al. Syndrome of inappropriate antidiuretic hormone secretion related to Guillain-Barré syndrome after laparoscopic cholecystectomy. Brazilian Journal of Anesthesiology. 2014; 64: 195–198.
[3] Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. The Lancet. 2021; 397: 1214–1228.
[4] Florian IA, Lupan I, Sur L, Samasca G, Timiș TL. To be, or not to be… Guillain-Barré syndrome. Autoimmunity Reviews. 2021; 20: 102983.
[5] Chuang T, Lin S, Chan R. Guillain-Barré syndrome: an unusual complication after snake bite. Archives of Physical Medicine and Rehabilitation. 1996; 77: 729–731.
[6] Srivastava A, Taly AB, Gupta A, Moin A, Murali T. Guillain-Barré syndrome following snake bite: an unusual complication. Annals of Indian Academy of Neurology. 2010; 13: 67–68.
[7] Neil J, Choumet V, Le Coupanec A, d’Alayer J, Demeret S, Musset L. Guillain-Barre syndrome: first description of a snake envenomation aetiology. Journal of Neuroimmunology. 2012; 242: 72–77.
[8] Neto EGC. Guillain-Barré syndrome after a snakebite: case report and literature review. Brazilian Journal of Neurology and Psychiatry. 2014; 18: 253–257.
[9] Kanni Y. Guillain-Barre syndrome (paraplegic variety) following snake bite. Journal of Basic and Clinical Research. 2017; 4: 26–27.
[10] Velu GV. Guillain-Barre syndrome: an unusual complication after a snake bite in a child. University Journal of Medicine and Medical Specialities. 2018; 4: 30.
[11] Hameed S, Memon M, Khan S. Guillain-Barre syndrome following a snakebite: a case report and review of literature. Cureus. 2019; 11: e5278.
[12] Suresh BV. Guillain-Barre syndrome following snake bite? An under-reported entity. IP Indian Journal of Neurosciences. 2021; 7: 181–183.
[13] Changadiya K, Anadure RK, Sreen A, Gupta S, Singh S, Mhatre R. Two unusual cases of Guillain-Barre syndrome after snake bite: the rare immune mediated complication of Elapid venom. Medical Journal Armed Forces India. 2023; 79: 321–327.
[14] Aradhey P, Gade N, Panjwani D, Kathpal J. Guillain-Barré’s syndrome post snake envenomation: rare case report and literature review. Neurology India. 2023; 71: 320.
[15] Bose S, Loo LK, Rajabally YA. Causes and consequences of diagnostic delay in Guillain-Barré syndrome in a UK tertiary center. Muscle Nerve. 2022; 65: 547–552.
[16] Lleixà C, Martín-Aguilar L, Pascual-Goñi E, Franco T, Caballero M, de Luna N, et al. Screening in Guillain-Barré syndrome. Journal of Neuroinflammation. 2021; 18: 251.
[17] Suhita R, Begum I, Rashid M, Chandran VP, Shastri SA, Kantamneni R, et al. Systematic review and meta-analysis of global prevalence of neurotoxic and hemotoxic snakebite envenomation. Eastern Mediterranean Health Journal. 2022; 28: 909–916.
[18] Huang YK, Chen YC, Liu CC, Cheng HC, Tu AT, Chang KC. Cerebral complications of snakebite envenoming: case studies. Toxins. 2022; 14: 436.
[19] Ranawaka UK, Lalloo DG, de Silva HJ. Neurotoxicity in snakebite—the limits of our knowledge. PLOS Neglected Tropical Diseases. 2013; 7: e2302.
[20] Seifert SA, Armitage JO, Sanchez EE. Snake envenomation. The New England Journal of Medicine. 2022; 386: 68–78.
[21] Prakash S, Mathew C, Bhagat S. Locked-in syndrome in snakebite. Journal of the Association of Physicians of India. 2008; 56: 121–122.
[22] Goyal JP, Shah VB. Suppression of brainstem reflexes in snakebite. Indian Pediatrics. 2009; 46: 360–361.
[23] Mathis S, Carla L, Duval F, Nadal L, Solé G, Le Masson G. Acute peripheral neuropathy following animal envenomation: a case report and systematic review. Journal of the Neurological Sciences. 2022; 442: 120448.
[24] Liang H, Cao Y, Zhong W, Ma Z, Liu J, Chen H. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: case report and scope review. Human Vaccines & Immunotherapeutics. 2022; 18: 2125753.
[25] Rath J, Zulehner G, Schober B, Grisold A, Krenn M, Cetin H, et al. Cerebrospinal fluid analysis in Guillain-Barré syndrome: value of albumin quotients. Journal of Neurology. 2021; 268: 3294–3300.
[26] Liu S, Dong C, Ubogu EE. Immunotherapy of Guillain-Barré syndrome. Human Vaccines & Immunotherapeutics. 2018; 14: 2568–2579.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 1.3 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.
Top